Body mass index, diabetes, and the risk of Parkinson's disease

被引:86
作者
Jeong, Su-Min [1 ,2 ,3 ]
Han, Kyungdo [4 ]
Kim, Dahye [4 ]
Rhee, Sang Youl [5 ,6 ]
Jang, Wooyoung [7 ]
Shin, Dong Wook [1 ,2 ,8 ,9 ]
机构
[1] Samsung Med Ctr, Dept Family Med, Seoul 135710, South Korea
[2] Samsung Med Ctr, Support Care Ctr, Seoul 135710, South Korea
[3] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[4] Catholic Univ Korea, Dept Med Stat, Coll Med, Seoul, South Korea
[5] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul, South Korea
[6] Scripps Translat Sci Inst, La Jolla, CA USA
[7] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Neurol, Kangnung, South Korea
[8] Sungkyunkwan Univ, Sch Med, Dept Family Med, Suwon, South Korea
[9] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Digital Hlth, Seoul, South Korea
关键词
body mass index; diabetes; Parkinson's disease; underweight; BETA-CELL DYSFUNCTION; INSULIN; GHRELIN; NEUROPROTECTION; EPIDEMIOLOGY; ASSOCIATION; PROTEINS; OBESITY;
D O I
10.1002/mds.27922
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background There are conflicting findings in the literature regarding the association of body mass index and incidence of PD. Objectives This study aimed to investigate the association of body mass index with the risk of PD incidence while considering diabetes mellitus as a major confounding factor. Methods We examined 6,800,601 individuals (aged >= 40 years) who were free of PD using the database of the Korean National Health Insurance Service. Cox proportional hazard regression was used to assess adjusted hazard ratios for PD with adjustment for potential confounders. Stratified analyses by diabetes status were also performed. Results A total of 33,443 individuals were diagnosed with PD during the follow-up period (7.3 years). An increased risk of PD incidence was observed in the underweight group versus the normal group (adjusted hazard ratio: 1.28; 95% confidence interval: 1.21-1.36), whereas a decreased risk of PD incidence was observed (adjusted hazard ratio: 0.88; 95% confidence interval: 0.88-0.93) in the obese group and (adjusted hazard ratio: 0.77; 95% confidence interval: 0.72-0.82) in the severely obese group. This association consistently persisted after stratification by diabetes mellitus status, with the steepest downward slope for PD risk present with increasing body mass index in patients with severe diabetes mellitus (i.e., long duration or complication). Conclusions Being underweight and diabetes mellitus were associated with an increased risk of PD incidence, and effect of being underweight was more prominent in those with diabetes mellitus, with a dose-response relationship existing according to diabetes mellitus status. Further research is warranted to understand the clinical implications of the significant interaction between being underweight and diabetes mellitus status in the development of PD. (c) 2019 International Parkinson and Movement Disorder Society
引用
收藏
页码:236 / 244
页数:9
相关论文
共 45 条
[1]   Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate [J].
Abu Fanne, Rami ;
Nassar, Taher ;
Heyman, Samuel N. ;
Hijazi, Nuha ;
Higazi, Abd Al-Roof .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2011, 301 (03) :R668-R673
[2]   The epidemiology of Parkinson's disease: risk factors and prevention [J].
Ascherio, Alberto ;
Schwarzschild, Michael A. .
LANCET NEUROLOGY, 2016, 15 (12) :1255-1270
[3]   Body weight in patients with Parkinson's disease [J].
Bachmann, Cornelius G. ;
Trenkwalder, Claudia .
MOVEMENT DISORDERS, 2006, 21 (11) :1824-1830
[4]   Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection [J].
Bayliss, Jacqueline A. ;
Andrews, Zane B. .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2013, 4 (01) :25-36
[5]   Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment [J].
Chaudhuri, K. Ray ;
Schapira, Anthony H. V. .
LANCET NEUROLOGY, 2009, 8 (05) :464-474
[6]   Obesity and the risk of Parkinson's disease [J].
Chen, HL ;
Zhang, SMM ;
Schwarzschild, MA ;
Hernán, MA ;
Willett, WC ;
Ascherio, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (06) :547-555
[7]  
Chen J, 2014, Int J Endocrinol, V2014, DOI DOI 10.1155/2014/203930
[8]   Insulin and neurodegenerative disease: shared and specific mechanisms [J].
Craft, S ;
Watson, GS .
LANCET NEUROLOGY, 2004, 3 (03) :169-178
[9]   Association between Parkinson's disease and diabetes: Data from NEDICES study [J].
De Pablo-Fernandez, E. ;
Sierra-Hidalgo, F. ;
Benito-Leon, J. ;
Bermejo-Pareja, F. .
ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (06) :732-736
[10]  
De Pablo-Fernandez E, 2018, NEUROLOGY, V91, pE139, DOI [10.1212/WNL.0000000000005771, 10.1212/wnl.0000000000005771]